313 related articles for article (PubMed ID: 21345765)
21. The Flatstent versus the conventional umbrella devices in the percutaneous closure of patent foramen ovale.
Aral M; Mullen M
Catheter Cardiovasc Interv; 2015 May; 85(6):1058-65. PubMed ID: 25413379
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous patent foramen ovale closure: outcomes with the Premere and Amplatzer devices.
Bissessor N; Wong AW; Hourigan LA; Jayasinghe RS; Scalia GS; Burstow DJ; Griffiths LR; Savage M; Walters DL
Cardiovasc Revasc Med; 2011; 12(3):164-169. PubMed ID: 21640934
[TBL] [Abstract][Full Text] [Related]
23. Second transcatheter closure for residual shunt following percutaneous closure of patent foramen ovale.
Susuri N; Obeid S; Ulmi M; Siontis GCM; Wahl A; Windecker S; Nietlispach F; Meier B; Praz F
EuroIntervention; 2017 Sep; 13(7):858-866. PubMed ID: 28437244
[TBL] [Abstract][Full Text] [Related]
24. Mid-term results of interventional closure of patent foramen ovale with the Occlutech Figulla
Neuser J; Akin M; Bavendiek U; Kempf T; Bauersachs J; Widder JD
BMC Cardiovasc Disord; 2016 Nov; 16(1):217. PubMed ID: 27832757
[TBL] [Abstract][Full Text] [Related]
25. Residual Shunt after Patent Foramen Ovale Device Closure in Patients With Cryptogenic Stroke: Serial Bubble Contrast Transesophageal Echocardiography Data.
Moon J; Kim M; Oh PC; Shin DH; Park HM; Jo YY; Lee JS; Kang WC
J Stroke Cerebrovasc Dis; 2019 Feb; 28(2):347-353. PubMed ID: 30396838
[TBL] [Abstract][Full Text] [Related]
26. The Case for Selective Patent Foramen Ovale Closure After Cryptogenic Stroke.
Wiktor DM; Carroll JD
Circ Cardiovasc Interv; 2018 Mar; 11(3):e004152. PubMed ID: 29870380
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous closure of the patent foramen ovale using the HELEX® Septal Occluder: acute and long-term results in 405 patients.
Heinisch C; Bertog S; Wunderlich N; Majunke N; Baranowski A; Leetz M; Fischer E; Staubach S; Zimmermann W; Hofmann I; Sievert H
EuroIntervention; 2012 Oct; 8(6):717-23. PubMed ID: 23086790
[TBL] [Abstract][Full Text] [Related]
28. Transseptal puncture to facilitate device closure of "long-tunnel" patent foramen ovale.
Thompson AJ; Hagler DJ; Taggart NW
Catheter Cardiovasc Interv; 2015 May; 85(6):1053-7. PubMed ID: 25380406
[TBL] [Abstract][Full Text] [Related]
29. Patent foramen ovale with complex anatomy: Comparison of two different devices (Amplatzer Septal Occluder device and Amplatzer PFO Occluder device 30/35).
Giordano M; Gaio G; Santoro G; Palladino MT; Sarubbi B; Golino P; Russo MG
Int J Cardiol; 2019 Mar; 279():47-50. PubMed ID: 30344060
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous PFO closure with Amplatzer PFO occluder: predictors of residual shunts at 6 months follow-up.
Greutmann M; Greutmann-Yantiri M; Kretschmar O; Senn O; Roffi M; Jenni R; Luescher TF; Eberli FR
Congenit Heart Dis; 2009; 4(4):252-7. PubMed ID: 19664027
[TBL] [Abstract][Full Text] [Related]
31. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
[TBL] [Abstract][Full Text] [Related]
32. Medium-term results of transcatheter closure of patent foramen ovale (PFO) with Amplatzer PFO and Cribriform occluders.
Białkowski J; Wawrzyńczyk M; Karwot B; Fiszer R; Knop M; Szkutnik M
Kardiol Pol; 2012; 70(11):1142-6. PubMed ID: 23180522
[TBL] [Abstract][Full Text] [Related]
33. Long-term follow-up after PFO device closure: Outcomes and Complications in a Single-center Experience.
Taggart NW; Reeder GS; Lennon RJ; Slusser JP; Freund MA; Cabalka AK; Cetta F; Hagler DJ
Catheter Cardiovasc Interv; 2017 Jan; 89(1):124-133. PubMed ID: 27027873
[TBL] [Abstract][Full Text] [Related]
34. Clinical evaluation of a novel occluder device (Occlutech) for percutaneous transcatheter closure of patent foramen ovale (PFO).
Krizanic F; Sievert H; Pfeiffer D; Konorza T; Ferrari M; Figulla HR
Clin Res Cardiol; 2008 Dec; 97(12):872-7. PubMed ID: 18696022
[TBL] [Abstract][Full Text] [Related]
35. Multidisciplinary assessment of PFO with substantial right-to-left shunting and medium-term follow-up after PFO device closure: A single-center experience.
He L; Cheng GS; Du YJ; Zhang YS
J Interv Cardiol; 2017 Aug; 30(4):362-367. PubMed ID: 28568903
[TBL] [Abstract][Full Text] [Related]
36. A Comparison Between Gore Cardioform and Amplatzer Septal Occluder for Percutaneous Closure of Patent Foramen Ovale Associated With Atrial Septal Aneurysm: Clinical and Echocardiographic Outcomes.
Musto C; Cifarelli A; Dipasquale F; Chin D; Nazzaro MS; Stio RE; Pennacchi M; De Felice F
J Invasive Cardiol; 2021 Nov; 33(11):E857-E862. PubMed ID: 34653958
[TBL] [Abstract][Full Text] [Related]
37. Simplified percutaneous closure of patent foramen ovale and atrial septal defect with use of plain fluoroscopy: Single operator experience in 110 consecutive patients.
Manolis AS; Koulouris S; Rouska E; Pyrros J
Indian Heart J; 2018; 70(1):24-31. PubMed ID: 29455783
[TBL] [Abstract][Full Text] [Related]
38. Residual Shunt After Patent Foramen Ovale Closure and Long-Term Stroke Recurrence: A Prospective Cohort Study.
Deng W; Yin S; McMullin D; Inglessis-Azuaje I; Elmariah S; Hung J; Lo EH; Palacios IF; Buonanno FS; Ning M
Ann Intern Med; 2020 Jun; 172(11):717-725. PubMed ID: 32422058
[TBL] [Abstract][Full Text] [Related]
39. The IrisFIT Patent Foramen Ovale Closure Device in Patients With History of Cryptogenic Embolization.
Hornung M; Bertog SC; Gafoor S; Reinartz M; Vaskelyte L; Hofmann I; Sievert K; Matic P; Grunwald I; Sievert H
J Invasive Cardiol; 2019 Nov; 31(11):319-324. PubMed ID: 31522140
[TBL] [Abstract][Full Text] [Related]
40. Multidisciplinary Assessment in Optimising Results of Percutaneous Patent Foramen Ovale Closure.
Davies A; Ekmejian A; Collins N; Bhagwandeen R
Heart Lung Circ; 2017 Mar; 26(3):246-250. PubMed ID: 27555053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]